Editorial: Advances in Diagnosing Drug Hypersensitivity Reactions

摘要

Like the previous one published in 2006 , this volume addresses literature regarding the pathogenic mechanisms, diagnosis, and prevention of drug hypersensitivity reactions, in order to improve the management of a problem in constant evolution. Specifically, the present issue provides an update on the main diagnostic methods of such reactions and supplements the information of the previous volume , discussing some topics, such as hypersensitivity reactions to biologic agents, nonaromatic anticonvulsants, macrolide antibiotics, anticoagulants, and antineoplastic drugs, not included in the latter.Also like the previous one , the present volume often refers to the general guidelines for diagnosing drug hypersensitivity reactions devised by the European Network for Drug Allergy (ENDA), the European Academy of Allergology and Clinical Immunology interest group on drug hypersensitivity; it contains articles by researchers and clinicians belonging to the ENDA and to the American Academy of Allergy, Asthma andImmunology Committee on Adverse Reactions to Drugs and Biologicals.